Assignee
EIRGEN PHARMA LTD
IE·6 granted patents·11 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
17 records- 0191US2026034148A1Stabilized modified release vitamin d formulation and method of administering sameEIRGEN PHARMA LTD·Filed 2025·Application pending·0 cites
- 0281US2025186464A1Methods of treating vitamin d insufficiency in chronic kidney diseaseEIRGEN PHARMA LTD·Filed 2024·Application pending·0 cites
- 0379US12478631B2Stabilized modified release vitamin D formulation and method of administering sameEIRGEN PHARMA LTD·Filed 2022·Granted Nov 25, 2025·0 cites·21 claims
- 0477US2025025423A1Pediatric dosage forms, methods of making and usingEIRGEN PHARMA LTD·Filed 2024·Application pending·0 cites
- 0576US12208106B2Methods of vitamin D treatmentEIRGEN PHARMA LTD·Filed 2021·Granted Jan 28, 2025·0 cites·15 claims
- 0675US11738033B2Adjunctive therapy with 25-hydroxyvitamin D and articles thereforEIRGEN PHARMA LTD·Filed 2021·Granted Aug 29, 2023·0 cites·24 claims
- 0773US2025144119A1Activating endogenous antimicrobials to treat sars-cov-2 infectionEIRGEN PHARMA LTD·Filed 2024·Application pending·0 cites
- 0872US2023346804A1Methods and compositions for reducing parathyroid levelsEIRGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 0969US12133917B2Pediatric dosage forms, methods of making and usingEIRGEN PHARMA LTD·Filed 2021·Granted Nov 5, 2024·0 cites·30 claims
- 1067US12433842B2Pediatric dosage forms, methods of making and usingEIRGEN PHARMA LTD·Filed 2021·Granted Oct 7, 2025·0 cites·19 claims
- 1161US2026076986A1A combination of scyllo-inositol and flavonesEIRGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1261US2023330110A1Hard capsule dosage form and uses thereofEIRGEN PHARMA LTD·Filed 2023·Application pending·0 cites
- 1358US2021308151A1Activating endogenous antimicrobials to treat sars-cov-2 infectionEIRGEN PHARMA LTD·Filed 2021·Application pending·0 cites
- 1453US2023293552A1Hard capsule dosage form and uses thereofEIRGEN PHARMA LTD·Filed 2021·Application pending·0 cites
- 1551US2022226351A1Method of Controlling Progression of Hyperparathyroidism, And Compositions for Use ThereinEIRGEN PHARMA LTD·Filed 2020·Application pending·0 cites
- 1649US2023096602A1Tetrahydrocyclopenta[b]indole compounds for treatment of renal diseaseEIRGEN PHARMA LTD·Filed 2021·Application pending·0 cites
- 1736US12441776B2Oxyntomodulin peptide analog formulationsEIRGEN PHARMA LTD·Filed 2019·Granted Oct 14, 2025·0 cites·20 claims
Join the waitlist — get patent alerts
Get an alert when EIRGEN PHARMA LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →